Transmission of murine cytomegalovirus in breast milk: A model of natural infection in neonates

Journal of Virology

Volumn 85, Issue 10, 2011, Pages 5115-5124

  Wu, Carol A ^a   Paveglio, Sara A ^a   Lingenheld, Elizabeth G ^a   Zhu, Li ^a   Lefrançois, Leo ^a   Puddington, Lynn ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN; BREAST FEEDING; BREAST MILK; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; FEMALE; LATENT VIRUS INFECTION; LEUKOCYTE; MOUSE; MURINE CYTOMEGALOVIRUS; NEWBORN; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEROCONVERSION; SOUTHERN BLOTTING; TISSUE DISTRIBUTION; VERTICAL TRANSMISSION; VIRUS REACTIVATION; VIRUS TRANSMISSION;

ANIMALS; ANIMALS, NEWBORN; CYTOMEGALOVIRUS INFECTIONS; DISEASE MODELS, ANIMAL; FEMALE; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; LEUKOCYTES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MILK, HUMAN; MUROMEGALOVIRUS;

CYTOMEGALOVIRUS; MAIZE CHLOROTIC MOTTLE VIRUS; MURID HERPESVIRUS 1; MUS;

EID: 79955371104     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01934-10     Document Type: Article

References (71)

1. Adler, S. P. 1991. Molecular epidemiology of cytomegalovirus: a study of factors affecting transmission among children at three day-care centers. Pediatr. Infect. Dis. J. 10:584-590.
2. Arvin, A. M., P. Fast, M. Myers, S. Plotkin, and R. Rabinovich. 2004. Vaccine development to prevent cytomegalovirus disease: report from the National Vaccine Advisory Committee. Clin. Infect. Dis. 39:233-239.
3. Ballard, R. A., W. L. Drew, K. G. Hufnagle, and P. A. Riedel. 1979. Acquired cytomegalovirus infection in preterm infants. Am. J. Dis. Child. 133:482-485.
4. Bantug, G. R., et al. 2008. CD8+ T lymphocytes control murine cytomegalovirus replication in the central nervous system of newborn animals. J. Immunol. 181:2111-2123.
5. Barkovich, A. J., and C. E. Lindan. 1994. Congenital cytomegalovirus infection of the brain: imaging analysis and embryologic considerations. AJNR Am. J. Neuroradiol. 15:703-715.
6. Brautigam, A. R., F. J. Dutko, L. B. Olding, and M. B. Oldstone. 1979. Pathogenesis of murine cytomegalovirus infection: the macrophage as a permissive cell for cytomegalovirus infection, replication and latency. J. Gen. Virol. 44:349-359.
7. Brune, W., H. Hengel, and U. H. Koszinowski. 2001. A mouse model for cytomegalovirus infection. Curr. Protoc. Immunol. 19.7.1-19.7.13. doi: 10.1002/0471142735.im1907s43.
8. Cekinovic, D., et al. 2008. Passive immunization reduces murine cytomegalovirus-induced brain pathology in newborn mice. J. Virol. 82:12172-12180.
9. Demmler, G. J. 1996. Congenital cytomegalovirus infection and disease. Adv. Pediatr. Infect. Dis. 11:135-162.
10. den Haan, J. M., and M. J. Bevan. 2002. Constitutive versus activation-dependent cross-presentation of immune complexes by CD8(+) and CD8(-) dendritic cells in vivo. J. Exp. Med. 196:817-827.
11. Diosi, P., L. Babusceac, O. Nevinglovschi, and G. Kun-Stoicu. 1967. Cytomegalovirus infection associated with pregnancy. Lancet ii:1063-1066.
12. Doctor, S., et al. 2005. Cytomegalovirus transmission to extremely low-birthweight infants through breast milk. Acta Paediatr. 94:53-58.
13. Doom, C. M., and A. B. Hill. 2008. MHC class I immune evasion in MCMV infection. Med. Microbiol. Immunol. 197:191-204.
14. Dworsky, M., M. Yow, S. Stagno, R. F. Pass, and C. Alford. 1983. Cytomegalovirus infection of breast milk and transmission in infancy. Pediatrics 72:295-299.
15. Fowler, K. B., A. J. Dahle, S. B. Boppana, and R. F. Pass. 1999. Newborn hearing screening: will children with hearing loss caused by congenital cytomegalovirus infection be missed? J. Pediatr. 135:60-64.
16. Fowler, K. B., S. Stagno, and R. F. Pass. 2003. Maternal immunity and prevention of congenital cytomegalovirus infection. JAMA 289:1008-1011.
17. Gartner, L. M., et al. 2005. Breastfeeding and the use of human milk. Pediatrics 115:496-506.
18. Griffith, B. P., J. T. Lavallee, T. A. Jennings, and G. D. Hsiung. 1985. Transmission of maternal cytomegalovirus-specific immunity in the guinea pig. Clin. Immunol. Immunopathol. 35:169-181.
19. Grundy, J. E., J. S. Mackenzie, and N. F. Stanley. 1981. Influence of H-2 and non-H-2 genes on resistance to murine cytomegalovirus infection. Infect. Immun. 32:277-286.
20. Hahn, G., R. Jores, and E. S. Mocarski. 1998. Cytomegalovirus remains latent in a common precursor of dendritic and myeloid cells. Proc. Natl. Acad. Sci. U. S. A. 95:3937-3942.
21. Hamprecht, K., et al. 2001. Epidemiology of transmission of cytomegalovirus from mother to preterm infant by breastfeeding. Lancet 357:513-518.
22. Hayashi, K., K. Saze, and Y. Uchida. 1985. Studies of latent cytomegalovirus infection: the macrophage as a virus-harboring cell. Microbiol. Immunol. 29:625-634.
23. Hayes, K., D. M. Danks, H. Gibas, and I. Jack. 1972. Cytomegalovirus in human milk. N. Engl. J. Med. 287:177-178.
24. Henry, S. C., et al. 2000. Enhanced green fluorescent protein as a marker for localizing murine cytomegalovirus in acute and latent infection. J. Virol. Methods 89:61-73.
25. Jonjic, S., et al. 1994. Antibodies are not essential for the resolution of primary cytomegalovirus infection but limit dissemination of recurrent virus. J. Exp. Med. 179:1713-1717.
26. Jordan, M. C., J. D. Shanley, and J. G. Stevens. 1977. Immunosuppression reactivates and disseminates latent murine cytomegalovirus. J. Gen. Virol. 37:419-423.
27. Koffron, A. J., et al. 1998. Cellular localization of latent murine cytomegalovirus. J. Virol. 72:95-103.
28. Kondo, K., H. Kaneshima, and E. S. Mocarski. 1994. Human cytomegalovirus latent infection of granulocyte-macrophage progenitors. Proc. Natl. Acad. Sci. U. S. A. 91:11879-11883.
29. Koontz, T., et al. 2008. Altered development of the brain after focal herpesvirus infection of the central nervous system. J. Exp. Med. 205:423-435.
30. Kosugi, I., et al. 2000. Cytomegalovirus infection of the central nervous system stem cells from mouse embryo: a model for developmental brain disorders induced by cytomegalovirus. Lab. Invest. 80:1373-1383.
31. Krmpotic, A., et al. 1999. The immunoevasive function encoded by the mouse cytomegalovirus gene m152 protects the virus against T cell control in vivo. J. Exp. Med. 190:1285-1296.
32. Kurz, S. K., et al. 1999. Focal transcriptional activity of murine cytomegalovirus during latency in the lungs. J. Virol. 73:482-494.
33. Li, R. Y., and Y. Tsutsui. 2000. Growth retardation and microcephaly induced in mice by placental infection with murine cytomegalovirus. Teratology 62:79-85.
34. Lin, E. Y., V. Gouon-Evans, A. V. Nguyen, and J. W. Pollard. 2002. The macrophage growth factor CSF-1 in mammary gland development and tumor progression. J. Mammary Gland Biol. Neoplasia 7:147-162.
35. Maidji, E., S. McDonagh, O. Genbacev, T. Tabata, and L. Pereira. 2006. Maternal antibodies enhance or prevent cytomegalovirus infection in the placenta by neonatal Fc receptor-mediated transcytosis. Am. J. Pathol. 168: 1210-1226.
36. Malinger, G., et al. 2003. Fetal cytomegalovirus infection of the brain: the spectrum of sonographic findings. AJNR Am. J. Neuroradiol. 24:28-32.
37. Malm, G., E. H. Grondahl, and I. Lewensohn-Fuchs. 2000. Congenital cytomegalovirus infection: a retrospective diagnosis in a child with pachygyria. Pediatr. Neurol. 22:407-408.
38. Maschmann, J., K. Hamprecht, K. Dietz, G. Jahn, and C. P. Speer. 2001. Cytomegalovirus infection of extremely low-birth weight infants via breast milk. Clin. Infect. Dis. 33:1998-2003.
39. Matson, A. P., R. S. Thrall, E. Rafti, E. G. Lingenheld, and L. Puddington. 2010. IgG transmitted from allergic mothers decreases allergic sensitization in breastfed offspring. Clin. Mol. Allergy 8:9.
40. Meier, J., et al. 2005. Human cytomegalovirus reactivation during lactation and mother-to-child transmission in preterm infants. J. Clin. Microbiol. 43:1318-1324.
41. Miron, D., et al. 2005. Incidence and clinical manifestations of breast milk-acquired cytomegalovirus infection in low birth weight infants. J. Perinatol. 25:299-303.
42. Mitchell, B. M., A. Leung, and J. G. Stevens. 1996. Murine cytomegalovirus DNA in peripheral blood of latently infected mice is detectable only in monocytes and polymorphonuclear leukocytes. Virology 223:198-207.
43. Nozawa, N., J. Fang-Hoover, T. Tabata, E. Maidji, and L. Pereira. 2009. Cytomegalovirus-specific, high-avidity IgG with neutralizing activity in maternal circulation enriched in the fetal bloodstream. J. Clin. Virol. 46(Suppl. 4):S58-S63.
44. Olver, S. D., P. Price, and G. R. Shellam. 1994. Cytomegalovirus hepatitis: characterization of the inflammatory infiltrate in resistant and susceptible mice. Clin. Exp. Immunol. 98:375-381.
45. Orange, J. S., T. P. Salazar-Mather, S. M. Opal, and C. A. Biron. 1997. Mechanisms for virus-induced liver disease: tumor necrosis factor-mediated pathology independent of natural killer and T cells during murine cytomegalovirus infection. J. Virol. 71:9248-9258.
46. Pass, R. F., E. A. Little, S. Stagno, W. J. Britt, and C. A. Alford. 1987. Young children as a probable source of maternal and congenital cytomegalovirus infection. N. Engl. J. Med. 316:1366-1370.
47. Pereira, L., E. Maidji, S. McDonagh, O. Genbacev, and S. Fisher. 2003. Human cytomegalovirus transmission from the uterus to the placenta correlates with the presence of pathogenic bacteria and maternal immunity. J. Virol. 77:13301-13314.
48. Perlman, J. M., and C. Argyle. 1992. Lethal cytomegalovirus infection in preterm infants: clinical, radiological, and neuropathological findings. Ann. Neurol. 31:64-68.
49. Pitt, J. 1979. The milk mononuclear phagocyte. Pediatrics 64:745-749.
50. Pollock, J. L., R. M. Presti, S. Paetzold, and H. W. Virgin IV. 1997. Latent murine cytomegalovirus infection in macrophages. Virology 227:168-179.
51. Pollock, J. L., and H. W. Virgin IV. 1995. Latency, without persistence, of murine cytomegalovirus in the spleen and kidney. J. Virol. 69:1762-1768.
52. Reddehase, M. J., et al. 1994. The conditions of primary infection define the load of latent viral genome in organs and the risk of recurrent cytomegalovirus disease. J. Exp. Med. 179:185-193.
53. Reuter, J. D., D. L. Gomez, J. H. Wilson, and A. N. van den Pol. 2004. Systemic immune deficiency necessary for cytomegalovirus invasion of the mature brain. J. Virol. 78:1473-1487.
54. Schuurhuis, D. H., et al. 2002. Antigen-antibody immune complexes empower dendritic cells to efficiently prime specific CD8+ CTL responses in vivo. J. Immunol. 168:2240-2246.
55. Siegrist, C. A., et al. 1998. Influence of maternal antibodies on vaccine responses: inhibition of antibody but not T cell responses allows successful early prime-boost strategies in mice. Eur. J. Immunol. 28:4138-4148.
56. Slavuljica, I., et al. 2010. Recombinant mouse cytomegalovirus expressing a ligand for the NKG2D receptor is attenuated and has improved vaccine properties. J. Clin. Invest. 120:4532-4545.
57. Soderberg-Naucler, C, et al. 2001. Reactivation of latent human cytomegalovirus in CD14(+) monocytes is differentiation dependent. J. Virol. 75: 7543-7554.
58. Stagno, S., and G. A. Cloud. 1994. Working parents: the impact of day care and breast-feeding on cytomegalovirus infections in offspring. Proc. Natl. Acad. Sci. U. S. A. 91:2384-2389.
59. Stagno, S., R. F. Pass, M. E. Dworsky, W. J. Britt, and C. A. Alford. 1984. Congenital and perinatal cytomegalovirus infections: clinical characteristics and pathogenic factors. Birth Defects Orig. Artic. Ser. 20:65-85.
60. Stagno, S., et al. 1982. Congenital cytomegalovirus infection: the relative importance of primary and recurrent maternal infection. N. Engl. J. Med. 306:945-949.
61. Stagno, S., D. W. Reynolds, R. F. Pass, and C. A. Alford. 1980. Breast milk and the risk of cytomegalovirus infection. N. Engl. J. Med. 302:1073-1076.
62. Stratton, K., J. Durch, and R. Lawrence. 2001. Vaccines for the 21st century: a tool for decision making. National Academy Press, Washington, DC.
63. Tassin, G. B., N. F. Maklad, R. R. Stewart, and M. E. Bell. 1991. Cytomegalic inclusion disease: intrauterine sonographic diagnosis using findings involving the brain. AJNR Am. J. Neuroradiol. 12:117-122.
64. Taylor-Wiedeman, J., P. Sissons, and J. Sinclair. 1994. Induction of endogenous human cytomegalovirus gene expression after differentiation of monocytes from healthy carriers. J. Virol. 68:1597-1604.
65. Trgovicich, J., E. Pernjak-Pugel, J. Tomac, U. Koszinowski, and S. Jonjic. 1998. Pathogenesis of murine cytomegalovirus infection in neonatal mice, p. 42-53. In M. Scholz, H. F. Rabenau, H. W. Doerr, and J. Cinatl, Jr. (ed.), CMV-related immunopathology. Monographs in virology, vol. 21. Karger, Basel, Switzerland.
66. Tsutsui, Y., A. Kashiwai, N. Kawamura, S. Aiba-Masago, and I. Kosugi. 1995. Prolonged infection of mouse brain neurons with murine cytomegalovirus after pre- and perinatal infection. Arch. Virol. 140:1725-1736.
67. van den Pol, A. N., E. Mocarski, N. Saederup, J. Vieira, and T. J. Meier. 1999. Cytomegalovirus cell tropism, replication, and gene transfer in brain. J. Neurosci. 19:10948-10965.
68. van den Pol, A. N., J. D. Reuter, and J. G. Santarelli. 2002. Enhanced cytomegalovirus infection of developing brain independent of the adaptive immune system. J. Virol. 76:8842-8854.
69. Vochem, M., K. Hamprecht, G. Jahn, and C. P. Speer. 1998. Transmission of cytomegalovirus to preterm infants through breast milk. Pediatr. Infect. Dis. J. 17:53-58.
70. Wirtz, N., et al. 2008. Polyclonal cytomegalovirus-specific antibodies not only prevent virus dissemination from the portal of entry but also inhibit focal virus spread within target tissues. Med. Microbiol. Immunol. 197:151-158.
71. Yeager, A. S. 1983. Transmission of cytomegalovirus to mothers by infected infants: another reason to prevent transfusion-acquired infections. Pediatr. Infect. Dis. 2:295-297.